Eric Warren - 17 Aug 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Chief Commercial Officer
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
17 Aug 2022
Transactions value $
-$1,356
Form type
4
Filing time
18 Aug 2022, 16:10:28 UTC
Previous filing
20 Jul 2022
Next filing
31 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale -$1.36K -199 -0.37% $6.82* 53K 17 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units.